BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

878 related articles for article (PubMed ID: 26011302)

  • 1. Insulin Resistance but Not Visceral Adiposity Index Is Associated with Liver Fibrosis in Nondiabetic Subjects with Nonalcoholic Fatty Liver Disease.
    Ercin CN; Dogru T; Genc H; Celebi G; Aslan F; Gurel H; Kara M; Sertoglu E; Tapan S; Bagci S; Rizzo M; Sonmez A
    Metab Syndr Relat Disord; 2015 Sep; 13(7):319-25. PubMed ID: 26011302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver disease.
    Petta S; Amato MC; Di Marco V; Cammà C; Pizzolanti G; Barcellona MR; Cabibi D; Galluzzo A; Sinagra D; Giordano C; Craxì A
    Aliment Pharmacol Ther; 2012 Jan; 35(2):238-47. PubMed ID: 22117531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease.
    Vongsuvanh R; George J; McLeod D; van der Poorten D
    J Hepatol; 2012 Aug; 57(2):392-8. PubMed ID: 22521350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Visceral Adiposity Index As a Practical Tool in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
    Vural Keskinler M; Mutlu HH; Sirin A; Erkalma Senates B; Colak Y; Tuncer I; Oguz A
    Metab Syndr Relat Disord; 2021 Feb; 19(1):26-31. PubMed ID: 32898457
    [No Abstract]   [Full Text] [Related]  

  • 5. Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease.
    Genc H; Dogru T; Kara M; Tapan S; Ercin CN; Acikel C; Karslioglu Y; Bagci S
    Ann Hepatol; 2013; 12(4):548-55. PubMed ID: 23813132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.
    Celebi G; Genc H; Gurel H; Sertoglu E; Kara M; Tapan S; Acikel C; Karslioglu Y; Ercin CN; Dogru T
    Saudi J Gastroenterol; 2015; 21(3):139-45. PubMed ID: 26021772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of high sensitivity C-reaction protein in non-insulin dependent diabetes mellitus patients with non-alcoholic fatty liver disease.
    Bi Y; Min M; Shen W; Deng P; Du Q; Dong M; Liu Y
    Int J Clin Exp Pathol; 2015; 8(7):8494-9. PubMed ID: 26339423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
    Fracanzani AL; Valenti L; Bugianesi E; Vanni E; Grieco A; Miele L; Consonni D; Fatta E; Lombardi R; Marchesini G; Fargion S
    J Hepatol; 2011 Jun; 54(6):1244-9. PubMed ID: 21145841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients.
    Díez-Rodríguez R; Ballesteros-Pomar MD; Calleja-Fernández A; González-De-Francisco T; González-Herráez L; Calleja-Antolín S; Cano-Rodríguez I; Olcoz-Goñi JL
    Rev Esp Enferm Dig; 2014 Dec; 106(8):522-8. PubMed ID: 25544409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of aerobic plus resistance training on the adipokines and neuropeptides in nonalcoholic fatty liver disease obese adolescents.
    de Piano A; de Mello MT; Sanches Pde L; da Silva PL; Campos RM; Carnier J; Corgosinho F; Foschini D; Masquio DL; Tock L; Oyama LM; do Nascimento CM; Tufik S; Dâmaso AR
    Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1313-24. PubMed ID: 22932160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
    Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
    Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of clinical and inflammatory markers of nonalcoholic fatty liver disease in postmenopausal women with metabolic syndrome.
    Rodrigues MH; Bruno AS; Nahas-Neto J; Sandrim VC; Muniz LG; Nahas EA
    Metab Syndr Relat Disord; 2014 Aug; 12(6):330-8. PubMed ID: 25051240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoadiponectinaemia in nonalcoholic fatty liver disease obese women is associated with infrequent intake of dietary sucrose and fatty foods.
    Magalhães GC; Feitoza FM; Moreira SB; Carmo AV; Souto FJ; Reis SR; Martins MS; Gomes da Silva MH
    J Hum Nutr Diet; 2014 Apr; 27 Suppl 2():301-12. PubMed ID: 23790128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
    Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
    J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum adiponectin levels are predictive of advanced hepatic fibrosis in patients with NAFLD.
    Savvidou S; Hytiroglou P; Orfanou-Koumerkeridou H; Panderis A; Frantzoulis P; Goulis J
    J Clin Gastroenterol; 2009 Sep; 43(8):765-72. PubMed ID: 19525862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HOMA-IR: An independent predictor of advanced liver fibrosis in nondiabetic non-alcoholic fatty liver disease.
    Fujii H; Imajo K; Yoneda M; Nakahara T; Hyogo H; Takahashi H; Hara T; Tanaka S; Sumida Y; Eguchi Y; Chayama K; Nakajima A; Nishimoto N; Kawada N;
    J Gastroenterol Hepatol; 2019 Aug; 34(8):1390-1395. PubMed ID: 30600551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral adiposity index is highly associated with adiponectin values and glycaemic disturbances.
    Al-Daghri NM; Al-Attas OS; Alokail MS; Alkharfy KM; Charalampidis P; Livadas S; Kollias A; Sabico SL; Chrousos GP
    Eur J Clin Invest; 2013 Feb; 43(2):183-9. PubMed ID: 23278387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
    du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
    Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visceral adiposity index as a predictor of NAFLD: A prospective study with 4-year follow-up.
    Xu C; Ma Z; Wang Y; Liu X; Tao L; Zheng D; Guo X; Yang X
    Liver Int; 2018 Dec; 38(12):2294-2300. PubMed ID: 30099825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.